Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Stadiums transcend their roles as mere sports venues; they embody iconic symbols of human achievement…
Hundreds of residents near Mount Ibu, an active volcano on Halmahera island in eastern Indonesia,…
India's strategic infrastructure development along its borders, particularly in regions like Ladakh and Arunachal Pradesh,…
In anticipation of increased demand in the automotive sector, Mahindra & Mahindra Ltd has unveiled…
In a recent briefing on the mid-year update of the World Economic Situation and Prospects…
In a significant development, senior Indian Police Service (IPS) officers A Y V Krishna and…